Carbapenem derivatives as potential inhibitors of various β-lactamases, including class B metallo-β-lactamases

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2497-2503

  Nagano, Rie ^a   Adachi, Yuka ^a   Imamura, Hideaki ^a   Yamada, Koji ^a   Hashizume, Terutaka ^a   Morishima, Hajime ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 4 METHYL 3 [5 (4 METHYLAMINOMETHYLPHENYL) 3 PYRROLIDINYLTHIO] 7 OXO 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFTAZIDIME; IMIPENEM; ISOENZYME; J 110441; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTEROIDES FRAGILIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; DRUG STRUCTURE; ENTEROBACTER CLOACAE; ENZYME INHIBITION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; STRAIN DIFFERENCE; STRUCTURE ACTIVITY RELATION;

EID: 0032879868     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2497     Document Type: Article

References (39)

1. Ambler, R. P. 1980. The structure of β-lactamases. Philos. Trans. R. Soc. Load. B Biol. Sci. 289:321-331.
2. IMP. Antimicrob. Agents Chemother. 39: 1612-1615.
3. Bush, K. 1989. Characterization of β-lactamases. Antimicrob. Agents Chemother. 33:259-263.
4. Bush, K., C. Macalintal, B. A. Ramussen, V. J. Lee, and Y. Yang. 1993. Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob. Agents Chemother. 37:851-858.
5. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
6. Carft, A., E. Dunee, M. Galleni, J. M. Frere, and O. Dideberg. 1997. Metallobeta-lactamase from Bacillus cereus 569h9. Brookhaven Protein Data Bank entry IBME.
7. Concha, N. O., B. A. Ramussen, K. Bush, and O. Herzberg. 1996. Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis. Structure 4:823-836.
8. Cornagalla, G., M. L. Riccio, A. Mazzariol, L. Lauretti, R. Fontana, and G. M. Rossolini. 1999. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 353:899-900.
9. Elison, G. B., S. Singer, and C. H. Hitchings. 1954. Antagonists of nucleic acid derivatives. VIII. Synergism in combination of biochemically related antimetabolites. J. Biol. Chem. 208:477-488.
10. Fabiane, S. M., M. K. Sofi, T. Wan, D. J. Payne, J. H. Bateson, T. Mitchell, and B. J. Sutton. 1998. Crystal structure of zinc-dependent β-lactamase from Bacillus cereus at 1.9A resolution: binuclear active site with features of a mononuclear enzyme. Biochemistry 37:12404-12411.
11. Fitzgerald, P. M. D., J. K. Wu, and J. H. Toney. 1998. Unanticipated inhibition of the metallo-β-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution. Biochemistry 37:6791-6800.
12. Gilpin, M. L., M. Fulston, D. Payne, H. Cramp, and I. Hood. 1995. Isolation and structure determination of two novel phenazines from a Streptomyces with inhibitory activity against metallo-enzymes, including metallo-β-lactamase. J. Antibiot. 48:1081-1085.
13. Hashizume, T., and R. Nagano. August 1998. Metallo-β-lactamase inhibitors. Japan patent 10-256065.
14. Imamura, H., N. Ohtake, A. Shimizu, H. Sato, Y. Sugimoto, S. Sakuraba, H. Kiyonaga, C. Suzuki-Sato, M. Nakano, R. Nagano, K. Yamada, T. Hashizume, and H. Morishima. Novel trans-3,5-disubstituted pyrrolidinylthio-1β-methylcarbapenems. Antibacterial activities of J-111,225, J-114,870, J-114,871 and their related compounds. Submitted for publication.
15. IMP among clinically isolated strains of Serratia marcescens. Antimicrob. Agents Chemother. 39:824-829.
16. Kahan, F. M., H. Kropp, J. G. Sundelof, and J. Birnbaum. 1983. Thienamycin: development of imipenem-cilastatin. J. Antimicrob. Chemother. 12 (Suppl. D):1-35.
17. Keynan, S., N. M. Hooper, A. Felici, G. Amicosante, and A. J. Turner. 1995. The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-β-lactamase enzyme CphA. Antimicrob. Agents Chemother. 39:1629-1631.
18. Laraki, N., N. Franceschini, G. M. Rossolini, P. Santucci, C. Meunier, E. D. Pauw, G. Amicosante, J. M. Frere, and M. Galleni. 1999. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-ß-lactamase IMP-1 produced by Escherichia coli. Antimicrob. Agents Chemother. 43: 902-906.
19. Lee, K., Y. Chong, H. B. Shin, and D. Yong. 1998. Rapid increase of imipenem-hydrolyzing Pseudomonas aeruginosa in a Korean hospital, abstr. E-85, p. 193. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Livermore, D. M. 1997. Acquired carbapenemases. J. Antimicrob. Chemother. 39:673-676.
21. Nagano, R, Y. Adachi, T. Hashizume, and H. Morishima. 1998. J-111,225 - a novel trans-3,5-disubstituted pyrrolidinylthio-1β-methyl-carbapenem: inhibitor of IMP-1 metallo-β-lactamase, abstr. F-55, p. 247. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
23. Ohsuka, S., Y. Arakawa, T. Norii, H. Ito, and M. Ohta. 1995. Effect of pH on activities of novel β-lactamases and β-lactamase inhibitors against these β-lactamases. Antimicrob. Agents Chemother. 39:1856-1858.
24. Ohtake, N., H. Imamura, H. Jona, H. Kijonaga, A. Shimizu, M. Moriya, S. Sato, M. Nakano, R. Ushijima, and S. Nakagawa. 1998. Novel dithiocarbamate carbapenems with anti-MRSA activity. Bioorg. Med. Chem. 6:1089-1101.
25. Payne, D. J., J. H. Bateson, B. C. Gasson, D. Proctor, T. Khushi, T. H. Farmer, D. A. Tolson, D. Bell, P. W. Skett, A. C. Marshall, R. Reid, L. Ghosez, Y. Combret, and J.-M. Brynaert. 1997. Inhibition of metallo-β-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob. Agents Chemother. 41:135-140.
26. Payne, D. J., K. Coleman, and R. Cramp. 1991. The automated in vitro assessment of β-lactamase inhibitors. J. Antimicrob. Chemother. 28:775-776.
27. Prosperi-Meys, C., G. Llabres, D. de Seny, R. P. Soto, M. H. Valladares, N. Laraki, J.-M. Frere, and M. Galleni. 1999. Interaction between class B ~β-lactamases and suicide substrates of active-site serine β-lactamases. FEBS Lett. 443:109-111.
28. Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
29. Sabath, L. D. 1968. Synergy of antimicrobial substances by apparently known mechanisms, p. 210-217. Antimicrob. Agents Chemother. 1967.
30. Saino, Y., F. Kobayashi, M. Inoue, and S. Mitsuhashi. 1982. Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob. Agents Chemother. 22:564-570.
31. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichikawa, K. Shimokawa, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.
32. IMP) in gram-negative rods resistant to broad-spectrum ~β-lactams. J. Clin. Microbiol. 34:2909-2913.
33. Shimizu, A., H. Sugimoto, S. Sakuraba, H. Imamura, H. Sato, N. Ohtake, R. Ushijima, S. Nakagawa, C. Suzuki, T. Hashizume, and H. Morishima. 1998. Novel trans-3,5-disubstituted pyrrolidinylthio-1-methylcarbapenems with potent activity against MRSA and Pseudomonas aeruginosa, abstr. F-52, p. 246, In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
34. Toney, J. H., P. M. Fitzgerald, N. Grover-Sharma, S. H. Olson, W. J. May, J. G. Sundelof, D. E. Vanderwall, K. A. Cleary, S. K. Grant, J. K. Wu, J. W. Kozarich, D. L. Pompliano, and G. G. Hammond. 1998. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase. Chem. Biol. 5:185-196.
35. Ullah, J., T. R. Walsh, I. A. Tailor, D. C. Emery, S. J. Gamblin, and J. Spencer. 1998. The crystal structure of the Ll metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7Å resolution. J. Mol. Biol. 284:125-136.
36. Waddell, S. T., R. W. Ratcliffe, S. P. Szumiloski, K. J. Wildonger, R. R. Wilkening, T. A. Blizzard, J. Huber, J. Kohler, K. Dorso, E. St. Rose, J. G. Sundelof, and G. G. Hammond. 1995. Benzothiazolylthio carhapenems: potent anti-MRSA agents. Bioorg. Med. Chem. Lett. 5:1427-1432.
37. Walter, M. W., A. Felici, M. Galleni, R. P. Soto, R. M. Adlinglon, J. E. Baldwin, J.-M. Frere, M. Gololobov, and C. J. Shofield. 1996. Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases. Bioorg. Med. Chem. 6:2455-2458.
38. Watanabe, S., D. Iyobe, M. Inoue, and S. Mitsuhashi. 1991. Transferable imipenem resistance in Pseudomonas aeruginosa, Antimicrob. Agents Chemother. 35:147-151.
39. Yang, Y., D. M. Roll, M. J. Wildey, M. Lee, M. Greenstein, W. M. Malese, and K. Bush. 1994. Inhibition of metallo-́-lactamases by LL-10G568α and LL-1OG568β, abstr. C56, p. 88. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.